Quick-Med Technologies Inc
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The c… Read more
Quick-Med Technologies Inc (QMDT) - Net Assets
Latest net assets as of June 2013: $-9.06 Million USD
Based on the latest financial reports, Quick-Med Technologies Inc (QMDT) has net assets worth $-9.06 Million USD as of June 2013.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($723.24K) and total liabilities ($9.78 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-9.06 Million |
| % of Total Assets | -1252.67% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Quick-Med Technologies Inc - Net Assets Trend (2002–2013)
This chart illustrates how Quick-Med Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Quick-Med Technologies Inc (2002–2013)
The table below shows the annual net assets of Quick-Med Technologies Inc from 2002 to 2013.
| Year | Net Assets | Change |
|---|---|---|
| 2013-06-30 | $-9.06 Million | -12.33% |
| 2012-06-30 | $-8.07 Million | -25.00% |
| 2011-06-30 | $-6.45 Million | -2.53% |
| 2010-06-30 | $-6.29 Million | -26.77% |
| 2009-06-30 | $-4.96 Million | -37.97% |
| 2008-06-30 | $-3.60 Million | -78.90% |
| 2007-06-30 | $-2.01 Million | -57.06% |
| 2006-06-30 | $-1.28 Million | -263.57% |
| 2005-06-30 | $-352.21K | +83.74% |
| 2004-06-30 | $-2.17 Million | -23.45% |
| 2003-06-30 | $-1.75 Million | -30.86% |
| 2002-06-30 | $-1.34 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Quick-Med Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2442903700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2013)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.73K | % |
| Other Comprehensive Income | $3.69K | % |
| Other Components | $19.29 Million | % |
| Total Equity | $-9.06 Million | 100.00% |
Quick-Med Technologies Inc Competitors by Market Cap
The table below lists competitors of Quick-Med Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hamilton Bancorp Inc
PINK:HABK
|
$0.95 |
|
FG Fitness & Media Group Inc
OTCGREY:FGFT
|
$0.95 |
|
Medican Enterprises
PINK:MDCN
|
$0.95 |
|
Heartsoft Inc
PINK:HTSF
|
$0.95 |
|
Terme Bancorp Inc
PINK:TMEB
|
$0.95 |
|
OJsys Inc
PINK:OJSY
|
$0.95 |
|
Urologix Inc
PINK:ULGX
|
$0.95 |
|
American Environmental Inc
PINK:MZPS
|
$0.95 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Quick-Med Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2012 to 2013, total equity changed from -8,065,074 to -9,059,877, a change of -994,803.
- Net loss of 713,073 reduced equity.
- Other comprehensive income increased equity by 3,689.
- Other factors decreased equity by 285,419.
Equity Change Factors (2012 to 2013)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-713.07K | -7.87% |
| Other Comprehensive Income | $3.69K | +0.04% |
| Other Changes | $-285.42K | -3.15% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Quick-Med Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-06-30 | $-0.11 | $0.00 | x |
| 2003-06-30 | $-0.13 | $0.00 | x |
| 2004-06-30 | $-0.13 | $0.00 | x |
| 2005-06-30 | $-0.02 | $0.00 | x |
| 2006-06-30 | $-0.04 | $0.00 | x |
| 2007-06-30 | $-0.07 | $0.00 | x |
| 2008-06-30 | $-0.12 | $0.00 | x |
| 2009-06-30 | $-0.16 | $0.00 | x |
| 2010-06-30 | $-0.20 | $0.00 | x |
| 2011-06-30 | $-0.20 | $0.00 | x |
| 2012-06-30 | $-0.22 | $0.00 | x |
| 2013-06-30 | $-0.24 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Quick-Med Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -76.80%
- • Asset Turnover: 1.28x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $-769.73K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.08 Million |
| 2004 | 0.00% | -4934.40% | 0.12x | 0.00x | $-2.15 Million |
| 2005 | 0.00% | -1060.59% | 0.15x | 0.00x | $-1.89 Million |
| 2006 | 0.00% | -138.25% | 2.34x | 0.00x | $-1.57 Million |
| 2007 | 0.00% | -77.12% | 2.02x | 0.00x | $-1.30 Million |
| 2008 | 0.00% | -175.61% | 1.50x | 0.00x | $-2.03 Million |
| 2009 | 0.00% | -201.31% | 2.04x | 0.00x | $-1.53 Million |
| 2010 | 0.00% | -357.18% | 0.74x | 0.00x | $-2.92 Million |
| 2011 | 0.00% | -221.55% | 0.63x | 0.00x | $-1.66 Million |
| 2012 | 0.00% | -169.11% | 1.63x | 0.00x | $-880.40K |
| 2013 | 0.00% | -76.80% | 1.28x | 0.00x | $192.91K |
Industry Comparison
This section compares Quick-Med Technologies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Quick-Med Technologies Inc (QMDT) | $-9.06 Million | 0.00% | N/A | $0.95 |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |